Giulia Cheloni, B.M., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplastic Stem Cells | 9 | 2020 | 1346 | 1.460 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 7 | 2020 | 685 | 1.270 |
Why?
|
Acriflavine | 1 | 2017 | 6 | 0.590 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2017 | 192 | 0.540 |
Why?
|
Cell Hypoxia | 1 | 2019 | 655 | 0.540 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2016 | 714 | 0.430 |
Why?
|
Neoplasms, Experimental | 2 | 2019 | 1228 | 0.420 |
Why?
|
Leukemia, Myeloid, Acute | 4 | 2021 | 3599 | 0.360 |
Why?
|
Leukemia | 1 | 2019 | 1519 | 0.360 |
Why?
|
Leukemia, Promyelocytic, Acute | 2 | 2021 | 251 | 0.310 |
Why?
|
Drug Delivery Systems | 1 | 2017 | 2212 | 0.260 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 3609 | 0.240 |
Why?
|
K562 Cells | 2 | 2017 | 639 | 0.240 |
Why?
|
Macrolides | 2 | 2016 | 205 | 0.230 |
Why?
|
Cancer Vaccines | 2 | 2022 | 1046 | 0.230 |
Why?
|
Stem Cell Niche | 2 | 2019 | 345 | 0.210 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2016 | 5249 | 0.200 |
Why?
|
Fusion Proteins, bcr-abl | 4 | 2016 | 431 | 0.180 |
Why?
|
Pyridazines | 1 | 2020 | 200 | 0.160 |
Why?
|
Oxygen | 4 | 2019 | 4191 | 0.160 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.160 |
Why?
|
Histones | 2 | 2021 | 2577 | 0.140 |
Why?
|
Tretinoin | 1 | 2019 | 519 | 0.130 |
Why?
|
NIH 3T3 Cells | 1 | 2017 | 670 | 0.130 |
Why?
|
Multiple Myeloma | 2 | 2023 | 5129 | 0.120 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5649 | 0.120 |
Why?
|
Imidazoles | 1 | 2020 | 1179 | 0.120 |
Why?
|
Arachidonate 15-Lipoxygenase | 1 | 2014 | 84 | 0.110 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2019 | 929 | 0.110 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1477 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2023 | 11709 | 0.090 |
Why?
|
Graft vs Host Disease | 1 | 2023 | 3024 | 0.090 |
Why?
|
Valproic Acid | 1 | 2013 | 442 | 0.090 |
Why?
|
Hydroxamic Acids | 1 | 2013 | 481 | 0.090 |
Why?
|
Chromatin | 1 | 2021 | 2938 | 0.080 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1664 | 0.080 |
Why?
|
Sarcoma | 1 | 2019 | 1785 | 0.080 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2013 | 772 | 0.070 |
Why?
|
Cell Survival | 1 | 2017 | 5781 | 0.070 |
Why?
|
DNA | 1 | 2021 | 7199 | 0.070 |
Why?
|
Dendritic Cells | 3 | 2023 | 2723 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2796 | 0.070 |
Why?
|
Glucose | 1 | 2019 | 4336 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 1 | 2019 | 3384 | 0.070 |
Why?
|
Transcription Factors | 3 | 2021 | 12094 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2022 | 5349 | 0.060 |
Why?
|
Mice | 7 | 2022 | 81101 | 0.060 |
Why?
|
Cell Line, Tumor | 5 | 2019 | 16886 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 11892 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 9574 | 0.050 |
Why?
|
Humans | 18 | 2023 | 758406 | 0.050 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2016 | 646 | 0.050 |
Why?
|
Animals | 8 | 2022 | 167768 | 0.050 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2023 | 886 | 0.040 |
Why?
|
Mice, Inbred C57BL | 4 | 2019 | 22003 | 0.040 |
Why?
|
Benzodiazepinones | 1 | 2018 | 50 | 0.040 |
Why?
|
U937 Cells | 1 | 2019 | 262 | 0.040 |
Why?
|
Tumor Stem Cell Assay | 1 | 2018 | 115 | 0.040 |
Why?
|
Transplantation, Autologous | 1 | 2023 | 2114 | 0.040 |
Why?
|
Proto-Oncogenes | 1 | 2019 | 320 | 0.040 |
Why?
|
Steroids | 1 | 2023 | 926 | 0.040 |
Why?
|
Cell Proliferation | 3 | 2018 | 10416 | 0.030 |
Why?
|
Dexamethasone | 1 | 2023 | 1927 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 2018 | 653 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 802 | 0.030 |
Why?
|
Lipoxygenase Inhibitors | 1 | 2014 | 93 | 0.030 |
Why?
|
Cell Count | 1 | 2018 | 1835 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2019 | 1090 | 0.030 |
Why?
|
Apoptosis | 3 | 2015 | 9468 | 0.030 |
Why?
|
Fluorenes | 1 | 2014 | 157 | 0.030 |
Why?
|
Exons | 1 | 2019 | 2387 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2021 | 1997 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13591 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2021 | 1740 | 0.030 |
Why?
|
P-Selectin | 1 | 2014 | 597 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2022 | 5490 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6127 | 0.020 |
Why?
|
Transfection | 1 | 2019 | 5779 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 2 | 2018 | 5629 | 0.020 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2013 | 350 | 0.020 |
Why?
|
Acetylation | 1 | 2013 | 1060 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2019 | 3432 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2019 | 4257 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3840 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8553 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4549 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3355 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2019 | 1634 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9267 | 0.020 |
Why?
|
Lysine | 1 | 2013 | 998 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5031 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9518 | 0.020 |
Why?
|
Cell Cycle | 1 | 2015 | 2930 | 0.020 |
Why?
|
DNA Damage | 1 | 2015 | 2439 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2019 | 14354 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10171 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8506 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2013 | 4485 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18119 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 18940 | 0.010 |
Why?
|
Aged | 2 | 2020 | 168218 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2013 | 11471 | 0.010 |
Why?
|
Middle Aged | 2 | 2020 | 219568 | 0.010 |
Why?
|
Adult | 2 | 2020 | 219935 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 29915 | 0.010 |
Why?
|
Signal Transduction | 1 | 2016 | 23342 | 0.010 |
Why?
|
Time Factors | 1 | 2013 | 39872 | 0.010 |
Why?
|
Male | 1 | 2020 | 358747 | 0.000 |
Why?
|
Female | 1 | 2020 | 390323 | 0.000 |
Why?
|